In rapidly expanding global biopharmaceutical market, the growing demand for drug development highlights the need for effective assessment tools in selecting biologic compounds. Samsung Biologics addresses this challenge with its advanced development platform, DEVELOPICK™, offering cutting-edge technology and an innovative approach from the early stages.
In this webinar, we explore how DEVELOPICK™ systematically screens molecules, identifying candidates with the best potential for progression to Investigational New Drug (IND) and Biological License Application (BLA).
In this webinar you’ll learn: